Table 1.
Reference | Study Design | [Initial FiO2] | Objectives | Outcomes |
---|---|---|---|---|
Harling 2005 [41] |
RCT GA < 31 weeks No PO; No SpO2 targets, n = 52 |
0.5 vs. 1.0 | ↓ lung inflammation | No significant differences in lung inflammation. It is possible to use lower FiO2. |
Stola 2005 [42] | Cohort WB < 1500 g PO & target SpO2; n = 100 |
Variable vs. 1.0 | Viability PaO2 at NICU admission | ↓ PaO2 at NICU admission with lower FiO2 Is possible to use less FiO2. |
Wang 2008 [43] |
RCT GA < 32 weeks PO & target SpO2; n = 41 |
0.21 vs. 1.0 | Viability; SpO2 targets: 80–85% at 5 min 85–90% at 7 min |
Supplemental O2 necessary in 21% group. |
Escrig 2008 [44] Vento 2009 [38] |
RCT GA < 28 weeks PO & target SpO2 n = 78 |
0.3 vs. 0.9 | SpO2 target 85% at 10 min Oxidative stress; Inflammation |
It is possible use less FiO2. Less oxidative stress and inflammation in 30% arm. |
Dawson 2009 [45] | Cohort GA < 30 weeks PO & target SpO2; n = 43 |
0.21 vs. 1.0 | Viability SpO2 target 90% at 10 min |
Supplemental O2 is necessary in 21% arm. Is possible to use less FiO2 |
Ezaki 2009 [46] | PO & target SpO2 n = 44 |
Variable vs. 1.0 | Oxidative stress | ↑ oxidative stress in 100% group. |
Rabi 2011 [47] | RCT GA < 32 weeks PO & target SpO2; n = 106 |
Static 1 vs 0.21 titrate or 1.0 titrate |
Viability SpO2 target 85–92% |
Titrating is more effective than static No differences in timing between the 3 groups to reach the target SpO2 range |
Armanian 2012 [48] |
RCT GA 29–34 weeks PO & target SpO2 n = 32 |
0.3 vs. 1.0 | SpO2 target 85% | It is possible to use less FiO2. |
Rook 2014 [49] | RCT GA < 32 weeks PO & target SpO2 n = 193 |
0.3 vs. 0.65 | Major neonatal illness Oxidative stress BPD 36 PMA SpO2 target 88–94% at 10 min |
30% is as safe as 65%. No differences in oxidate stress or BPD. No differences in oxidative stress biomarkers |
Kapadia 2013 [37] | RCT GA 24–34 weeks PO & target SpO2 n = 193 |
0.21 vs. 1.0 | Oxidative stress Short-term morbidities SpO2 target 88–94% |
It is possible to use less FiO2 Using 21% resulted in less oxidative stress, neonatal morbidities, and need for oxygen supplementation. |
Aguar 2013 [50] | RCT GA < 30 weeks PO & target SpO2 n = 60 |
0.30 vs. 0.60 | Death at 28 days and morbidities SpO2 target 88–94% at 10 min |
It is possible to use less FiO2 No differences in oxidative stress, neonatal morbidities, or mortality. |
Oei 2017 [51] | RCT GA < 32 weeks PO & target SpO2 n = 287 |
0.21 vs. 1.0 | Major disability and death at 2 y SpO2 target 65–95% at 5 min and 85–95% until NICU admission |
Increased risk of death in infants <28 weeks in the lower FiO2 group. |
Abbreviations: RCT: Randomized controlled trial; PO: Pulse oximetry; GA: Gestational age; BPD: Bronchopulmonary dysplasia; PMA: Postmenstrual age; SpO2: Oxygen saturation; FiO2: Inspired fraction of oxygen; WB: Weight birth; NICU: Neonatal intensive care unit; PaO2: Arterial partial pressure of oxygen. ↑ is increase and ↓ is decrease.